In the ongoing battle against cancer, a stark reality continues to emerge: women face unique challenges, which disproportionally puts their health and lives at risk.
Research shows that by 2030, the global mortality rate for women due to cancer will surge by 60 per cent (American Cancer Society). In Canada, while the rate of cancer incidence has stabilized for men, diagnoses among women continues to climb, pointing to a glaring gap in understanding the intricacies of this disease.
Amidst this complex landscape, The Peter Gilgan Centre for Women’s Cancers at Women’s College Hospital, stands as a beacon of hope, spearheading efforts to accelerate research and bridge gaps in prevention, treatment, and survivorship.
“Women’s cancer care demands a targeted approach. It’s not just about acknowledging gender differences; it’s about recognizing the unique experiences and challenges faced by women throughout their cancer journeys.”
Key factors contributing to the surge in cancer incidence amongst women include an aging population and shifting health patterns. More research is needed to understand how these factors impact different women and equity deserving populations, at distinct stages of life. Dr. Lofters draws parallels to historical trends, likening the situation to the gradual cessation of smoking among men while witnessing an increase among women. “It’s crucial to recognize the social and cultural shifts affecting women and their health, and tailor interventions accordingly.”
Women in Canada are also more likely to receive a cancer diagnosis during their prime years of life – when they are often primary caregivers for their family members, and balancing career and personal demands, further underscoring the urgency for understanding the disparities faced by women.
Rising cancer rates also cause growing economic burden on society more broadly. The Public Health Agency of Canada notes that cancer accounts for $4.4 billion in economic costs each year, including $3.8 billion in healthcare costs and $586 million in indirect costs such as loss of workforce productivity.
While balancing careers and managing familial responsibilities, women who face a cancer diagnosis are often left to navigate a complex network of new challenges. Dr. Lofters emphasizes the importance of a comprehensive approach that addresses medical needs and social determinants of health, and meets women where they are: “We need to go beyond traditional medical care and address the broader social factors affecting women’s health.”
The Centre’s multifaceted approach is easing the burden on women and the healthcare system. Through partnerships with organizations like The Olive Branch of Hope, the Centre leads on critical programming like the Breast and Cervical Screening for Black Women, targeting hard-to-reach women within the community and arming them with the knowledge and care they need to prioritize their health and reduce their risk of developing cancer.
“Engagement with local organizations is vital in increasing access to screenings and education, particularly among communities that have been marginalized, or for whom healthcare institutions have not been safe,” said Dr. Lofters.
Dr. Lofters is optimistic about the future of cancer care for women. “We’re at the forefront of cancer research, treatment, and prevention for women,” she says. “By building bridges within the healthcare system and fostering community partnerships, we’re paving the way for a future where women’s cancers are not only treatable but are also preventable.”
In partnership with the Canadian Cancer Society, the Peter Gilgan Centre for Women’s Cancers targets interventions that address the unique needs of women with cancer.